Dec 08, 2020 04:21 PM IST
Gates praised India for building ambitious platforms for universal identification and digital payments which include the world’s largest biometric database and a system for sending rupees between any bank or smartphone app.
- Nov 30, 2020 05:37 PM IST
The 40-year-old volunteer claimed that he contracted severe neurological disorders after being vaccinated with Covidshield shots under development at Serum Institute of India. All you need to know about the legal hassle.
- Sep 09, 2020 04:07 PM IST
Among coronavirus vaccines currently under development, the AstraZeneca-Oxford vaccine is seen as one of the most promising candidates.
- Aug 07, 2020 02:59 PM IST
For this, the Gates Foundation will provide an at-risk funding of $150 million to GAVI, with the pricing capped at a maximum of $3 per dose.
- Jul 27, 2020 10:00 PM IST
About 6,000 health workers and high-risk individuals including those in close contact of COVID-19 patients have been enrolled in a clinical trial to determine if the recombinant Bacillus Calmette-Guerian (rBCG) can boost immunity to fight against the virus, the statement added.
- Jun 26, 2020 04:39 PM IST
Investment banks Goldman Sachs, Citi and Avendus Capital have been engaged as advisors for the process by the privately held vaccine manufacturer, say sources.
- Apr 30, 2020 01:26 PM IST
The Serum Institute of India said on Tuesday it plans this year to produce up to 60 million doses of a potential vaccine against the new coronavirus that is under clinical trial in Britain.
- Apr 29, 2020 07:22 AM IST
Serum, the world's largest maker of vaccines by volume, is mass-producing the vaccine candidate developed by the University of Oxford, which started testing it on humans last week, and is a leader in the global race to develop an antidote to the novel coronavirus.
- Apr 26, 2020 03:40 PM IST
The Pune-based company has partnered with Oxford University as one of the seven global institutions manufacturing the vaccine.
- Sep 11, 2019 05:13 PM IST
With a net worth of $13 billion, Poonawalla is the fourth richest person in India and 100th in the world, according to Hurun Global Rich List - 2019.
- Jul 05, 2018 02:10 PM IST
Adar Poonawala took over from his father Cyrus, to guide the fortunes of the group. In an exclusive interview, he spoke about some of the group’s initiatives.
- Jan 21, 2017 02:51 PM IST
Adar Poonawala, CEO of Serum Institute, believes that a bigger partnership with Cipla will create a big Indian conglomerate. However, he added that the Cipla promoters currently have no plans for a merger and acquisition.
- Jan 07, 2016 08:52 PM IST
Serum Institute CEO Adar Poonawala has told CNBC-TV18 that Cipla and Serum will not be merging anytime soon. Cipla and Serum Institute have joined hands to sell products jointly across various countries in the world.
- Sep 22, 2015 04:54 PM IST
Serum Chief executive officer Adar Poonawalla says the company has entered into an exclusive agreement with US-based Visterra for developing a dengue antibody.
- Mar 26, 2015 07:22 PM IST
Winners of this years EY Entrepreneur of the Year 2014 Awards are an inspiration in themselves and to pay tribute to their triumphs we bring to you a very special series called Passion to Win. Our achiever today is responsible for the immunisation of 65 percent of the global infant population - Dr Cyrus Poonawala.
- Feb 06, 2015 05:16 PM IST
Billionnaire Cyrus Poonawalla, founder of the world‘s biggest vaccine maker Serum Institute, has told CNBC-TV18 that after the company tied up with drugmaker Cipla to sell its vaccines in Europe late last year, Serum is now exploring the option of merging with it.
- Sep 26, 2012 11:00 PM IST
CNBC-TV18's Archana Shukla finds out Poonawala‘s strategy that is winning him accolades in the world of vaccines.
- Mar 27, 2012 10:43 PM IST
The world of pediatric vaccines is about to be shaken. And it's Hyderabad based Shantha Biotech that's going to do all the shaking